All Cats Considered – Episode 322
In this episode of All Cats Considered, host Yaiza Gómez-Mejías, LdaVet MANZCVS (Medicine of Cats), RCVS CertAP (Feline Medicine), is joined by Natalie Finch BVSc, PhD, DipECVIM-CA, FRCVS, and Sam Taylor BVetMed (Hons) CertSAM DipECVIM-CA MANZCVS FRCVS, Veterinary Specialist Consultant and Veterinary Specialist Lead at iCatCare to discuss the newly released 2026 iCatCare consensus guidelines on the diagnosis and management of chronic kidney disease in cats. The conversation provides an overview of the key updates since the previous consensus guidelines, including advances in early diagnosis, the evolving roles of creatinine and SDMA, new insights into dietary phosphate and CKD progression, and an improved understanding of conditions such as nephrolithiasis, nephrocalcinosis, CKD-mineral and bone disorder, and diet-induced hypercalcemia.
Drs. Finch and Taylor also explore emerging approaches to CKD management, including the use of FGF-23, novel treatments for CKD-associated anemia, and the potential role of the gut microbiome in disease progression. The discussion highlights the importance of proactive screening and early detection while emphasizing practical strategies to preserve quality of life through individualized care. In addition, they discuss the value of a team-based approach involving veterinarians, nurses, and caregivers, the impact of caregiver burden, and the importance of applying the Five Pillars of a Healthy Feline Environment to support both the physical and emotional well-being of cats living with CKD. This episode offers a concise introduction to the guidelines and the latest evidence-based recommendations for one of the most common feline diseases encountered in clinical practice.
Additional Resources:
Read the full guidelines in the Journal of Feline Medicine and Surgery:
2026 iCatCare consensus guidelines on the diagnosis and management of chronic kidney disease in cats